Log in
Enquire now
‌

US Patent 10683285 Modulators of hemoglobin

Patent 10683285 was granted and assigned to Global Blood Therapeutics on June, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Global Blood Therapeutics
Global Blood Therapeutics
0
Date Filed
November 18, 2019
0
Date of Patent
June 16, 2020
0
Patent Applicant
Global Blood Therapeutics
Global Blood Therapeutics
0
Patent Application Number
16687474
0
Patent Citations
‌
US Patent 10100040 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10100043 Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
‌
US Patent 10137118 Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
‌
US Patent 10266551 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10315991 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10377741 Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
‌
US Patent 10450269 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10435393 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 10493035 Tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
‌
US Patent 10004725 Methods of treatment
•••
Patent Citations Received
‌
US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 11851424 Solid forms of a modulator of hemoglobin
0
‌
US Patent 11939323 Methods of making a modulator of hemoglobin
0
‌
US Patent 11530191 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 11548880 Modulators of hemoglobin
‌
US Patent 10858317 Compounds and uses thereof for the modulation of hemoglobin
‌
US Patent 11001588 Activating pyruvate kinase R and mutants thereof
‌
US Patent 11014884 Modulators of hemoglobin
‌
US Patent 11014927 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
‌
US Patent 11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10683285
0
Patent Primary Examiner
‌
Karen Cheng
0

Find more entities like US Patent 10683285 Modulators of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.